Thank you for subscribing!
Finfeed Archived Feb 17, 2021
Creso Pharma Limited (ASX:CPH, FRA:1X8) has announced that its wholly-owned Canadian subsidiary Mernova Medicinal Inc. has secured four purchase orders (“PO”) for its leading Ritual Green product range, with a total value of C$494,131 (A$502,199).
Finfeed Archived Feb 03, 2021
Investors who took a stake in Creso Pharma (ASX:CPH) three months ago are now looking at a near ten-bagger, with more upside to come.
Next Investors Jan 19, 2021
Today Creso Pharma (ASX: CPH) reported new and follow up Purchase Orders for its animal health medicinal cannabis products totalling over A$345,000.
Finfeed Archived Dec 21, 2020
Creso Pharma Limited (ASX: CPH, FRA: 1X8) has secured regulatory approval from the Ministry of Agriculture and Animal Feed in Uruguay (Ministerio de Ganadaria, Agricultura y Pesca) through its commercial partner Adler Laboratories, Uruguay for its line of animal health products, anibidiol®.
Get expert stock analysis direct in your inbox
Finfeed Archived Dec 11, 2020
Roots Sustainable Agricultural Technologies Limited (ASX: ROO) has secured a Non-binding Letter of Intent (LOI) with smart technology provider, Humboldt CCTV to integrate its proprietary Root Zone Temperature Optimisation (RZTO) technology and revolutionary heat exchange stub product into Humboldt’s Smart Agriculture solution.
Catalyst Hunter Dec 07, 2020
Creso Pharma Limited (ASX: CPH) has substantial operations in North America and the US decision to legalise cannabis paves the way for the company to enter into the world’s largest recreational and medical cannabis market.
Finfeed Archived Dec 07, 2020
Creso Pharma Limited (ASX: CPH; FRA: 1X8) has advised that the US House of Representatives has passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act to remove cannabis for the US Controlled Substances Act.
Next Investors Dec 02, 2020
Over recent days, Creso Pharma (ASX: CPH) appears to have gained some significant momentum. Momentum includes three new purchase orders for Creso Pharma’s anibidiol® line of animal health products were signed today, to a value of $A$414,000.
Finfeed Archived Oct 27, 2020
Through its Mernova subsidiary, Creso Pharma (ASX: CPH) has delivered its third purchase order (PO) from the Nova Scotia Liquor Corp
Join Our Mailing List
